To view or add a comment, sign in I definitely agree with the following statement discussing the next phase of potentially making precision psychiatry a reality The proposal is straightforward: Move toward biomarker-driven patient stratification Design more flexible, biology-informed clinical trials Align regulatory approaches with what already works in oncology and dementia Dementia offers a useful reference point
Zinc deficiencies, which are very common, lead to increased copper levels, as well as low ceruloplasmin, all of which translates into elevated 'free copper'
Buen servicio
It allows you to understand whats going on with your biology in real time, to put your biology online, [and] to have it really give you insights about whats happening. To do so, Function Health has an in-person partnership with Quest Diagnostics, the labs business with more than 6,000 locations across the country
For patients who are 20/10 mm Hg greater than their goal BP, 2-drug combination therapy should be strongly considered